Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $161,590 | 100 | 67.8% |
| Consulting Fee | $32,130 | 11 | 13.5% |
| Travel and Lodging | $21,774 | 103 | 9.1% |
| Food and Beverage | $20,343 | 468 | 8.5% |
| Honoraria | $2,250 | 2 | 0.9% |
| Education | $287.84 | 4 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Products, LP | $79,150 | 108 | $0 (2023) |
| Gilead Sciences, Inc. | $62,343 | 178 | $0 (2024) |
| ABBVIE INC. | $59,738 | 135 | $0 (2024) |
| ViiV Healthcare Company | $29,584 | 129 | $0 (2024) |
| Theratechnologies Inc. | $4,206 | 17 | $0 (2023) |
| Janssen Biotech, Inc. | $2,691 | 98 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $227.61 | 2 | $0 (2019) |
| GlaxoSmithKline, LLC. | $68.73 | 3 | $0 (2024) |
| Global Blood Therapeutics, Inc. | $65.63 | 3 | $0 (2021) |
| Novo Nordisk Inc | $62.29 | 3 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $4,245 | 21 | ABBVIE INC. ($3,725) |
| 2023 | $16,578 | 61 | Gilead Sciences, Inc. ($9,234) |
| 2022 | $18,402 | 84 | ABBVIE INC. ($8,015) |
| 2021 | $17,879 | 64 | AbbVie Inc. ($7,146) |
| 2020 | $20,311 | 50 | ViiV Healthcare Company ($7,708) |
| 2019 | $58,530 | 144 | AbbVie, Inc. ($21,279) |
| 2018 | $53,042 | 134 | Gilead Sciences, Inc. ($15,896) |
| 2017 | $49,388 | 130 | Janssen Products, LP ($21,591) |
All Payment Transactions
688 individual payment records from CMS Open Payments — Page 1 of 28
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/13/2024 | ABBVIE INC. | MAVYRET (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,250.00 | General |
| Category: VIROLOGY | ||||||
| 11/07/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: VIROLOGY | ||||||
| 10/10/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $18.48 | General |
| 09/11/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $22.01 | General |
| 09/06/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Food and Beverage | In-kind items and services | $28.85 | General |
| Category: VACCINES | ||||||
| 08/07/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $21.50 | General |
| 06/17/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $24.16 | General |
| 06/12/2024 | CeQur Corporation | CeQur Simplicity (Device) | Food and Beverage | Cash or cash equivalent | $19.36 | General |
| Category: Diabetes | ||||||
| 06/05/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $14.94 | General |
| Category: Endocrinology | ||||||
| 05/20/2024 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $32.90 | General |
| Category: HIV | ||||||
| 04/02/2024 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $23.67 | General |
| Category: HIV | ||||||
| 03/28/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $32.96 | General |
| 03/28/2024 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $30.42 | General |
| Category: HIV | ||||||
| 03/25/2024 | ViiV Healthcare Company | — | Food and Beverage | In-kind items and services | $122.19 | General |
| 03/09/2024 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $10.66 | General |
| Category: HIV | ||||||
| 03/07/2024 | ABBVIE INC. | MAVYRET (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,350.00 | General |
| Category: VIROLOGY | ||||||
| 02/27/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $18.57 | General |
| 01/31/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $25.36 | General |
| Category: Cardio-renal | ||||||
| 01/12/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $32.64 | General |
| 01/12/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $20.35 | General |
| 01/03/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Food and Beverage | In-kind items and services | $20.70 | General |
| Category: VACCINES | ||||||
| 11/17/2023 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $30.97 | General |
| Category: HIV | ||||||
| 11/14/2023 | Theratechnologies Inc. | EGRIFTA (Drug), TROGARZO | Food and Beverage | In-kind items and services | $61.49 | General |
| Category: HIV | ||||||
| 11/03/2023 | ViiV Healthcare Company | CABENUVA (Biological) | Food and Beverage | In-kind items and services | $6.68 | General |
| Category: HIV | ||||||
| 10/16/2023 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $33.22 | General |
| Category: HIV | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 16 | 56 | $15,924 | $4,496 |
| 2022 | 1 | 17 | 47 | $13,563 | $3,950 |
| 2021 | 1 | 16 | 64 | $18,674 | $5,433 |
| 2020 | 1 | 25 | 54 | $12,923 | $3,631 |
All Medicare Procedures & Services
5 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 16 | 56 | $15,924 | $4,496 | 28.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 17 | 47 | $13,563 | $3,950 | 29.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 16 | 64 | $18,674 | $5,433 | 29.1% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 12 | 39 | $9,098 | $2,856 | 31.4% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 13 | 15 | $3,825 | $774.77 | 20.3% |
About Dr. Samuel Uter, MD
Dr. Samuel Uter, MD is a Internal Medicine healthcare provider based in Brooklyn, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/02/2006. The National Provider Identifier (NPI) number assigned to this provider is 1699713792.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Samuel Uter, MD has received a total of $238,375 in payments from pharmaceutical and medical device companies, with $4,245 received in 2024. These payments were reported across 688 transactions from 21 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($161,590).
As a Medicare-enrolled provider, Uter has provided services to 74 Medicare beneficiaries, totaling 221 services with total Medicare billing of $17,510. Data is available for 4 years (2020–2023), covering 5 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Brooklyn, NY
- Active Since 06/02/2006
- Last Updated 10/29/2009
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1699713792
Products in Payments
- Mavyret (Drug) $31,432
- SYMTUZA (Drug) $23,210
- PREZCOBIX (Drug) $22,993
- Symtuza (Drug) $22,343
- MAVYRET (Drug) $21,333
- Biktarvy (Drug) $14,962
- Genvoya (Drug) $7,415
- DOVATO (Drug) $5,197
- EGRIFTA (Drug) $2,666
- TROGARZO (Drug) $1,540
- JULUCA (Drug) $1,230
- TIVICAY (Drug) $800.57
- CABENUVA (Biological) $227.18
- Vemlidy (Drug) $223.14
- APRETUDE (Biological) $175.05
- Viekira (Drug) $171.71
- Truvada (Drug) $143.42
- Descovy (Drug) $121.89
- SHINGRIX (Biological) $68.73
- OXBRYTA (Drug) $65.63
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Brooklyn
Bruce Berger, M.d, M.D
Internal Medicine — Payments: $3.0M
Dr. Jesi Ramone, Md, MD
Internal Medicine — Payments: $701,491
Dr. Ali El Atat, M.d, M.D
Internal Medicine — Payments: $426,309
Manish Parikh, Md, MD
Internal Medicine — Payments: $360,332
Dr. Bharath Reddy, Md, MD
Internal Medicine — Payments: $159,733
Sima Muster
Internal Medicine — Payments: $137,530